Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
暂无分享,去创建一个
J. Blay | G. Demetri | A. Cesne | A. Italiano | R. Maki | P. Hohenberger | H. Gelderblom | P. Schöffski | Shreyaskumar R Patel | S. Rha | S. Bauer | G. Grignani | B. Chmielowski | S. Chawla | E. Choy | D. D’Adamo | M. Guo | V. Camargo